Specifically, we observed that mothers with moderate to severe infections had significantly higher concentrations of anti-S1RBD-IgA and -IgG in transitional milk and significantly higher concentrations of anti-S1RBD-IgA and -IgM in mature milk than mothers with no to mild COVID-19 symptoms. This evidence concerns the gene CD79A and COVID-19.